The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
CBLL · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
NHC · Healthcare · Narrow moat
On the watchlist
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | BVS | CBLL | ACAD | NHC |
|---|---|---|---|---|
| Moat Score (0–100) | 61 (highest) | 61 (highest) | 61 (highest) | 60 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 74 | 70 | 80 (highest) | 67 |
| Pricing power | 97 | 100 (highest) | 98 | — |
| Returns on capital | 7 (highest) | — | 4 | 3 |
| Balance-sheet safety | 67 | 28 | 100 (highest) | 100 (highest) |
| Capital allocation | 58 | 47 | 24 | 71 (highest) |
| 489% above value if growth stopped today | No price data | No price data | 171% above value if growth stopped today (largest discount to value if growth stopped today) | |
| Market cap | $813M | $634M | $4.2B | $3.5B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |